What is the global incidence of infective endocarditis (IE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The global incidence of infective endocarditis is estimated to range from 3 to 10 episodes per 100,000 person-years, with a significant increase in incidence observed in older adults, particularly those between 70 and 80 years of age, with a peak incidence of 14.5 episodes per 100,000 person-years 1. The incidence of infective endocarditis varies by region and population characteristics, with methodological differences between surveys potentially contributing to this variation 1.

  • Key factors influencing the incidence of infective endocarditis include:
    • Age, with a dramatic increase in incidence observed in older adults
    • Sex, with a male:female ratio of 2:1, although the higher proportion of men is poorly understood
    • Pre-existing valvular heart disease, prosthetic heart valves, and other underlying health conditions
  • The epidemiology of infective endocarditis has shifted in recent decades, with a growing proportion of cases occurring in elderly patients with healthcare exposure rather than in younger patients with rheumatic heart disease.
  • Early diagnosis and appropriate antimicrobial therapy are crucial for improving outcomes in infective endocarditis, given the significant mortality rates associated with this infection, ranging from 15-30% during initial hospitalization and approximately 40% at one year 1.

From the Research

Incidence of Infective Endocarditis

  • The incidence of infective endocarditis is estimated to be between 30 and 80 cases per million inhabitants per year in the general population in industrialized countries 2.
  • A study published in 2000 estimated the incidence of infective endocarditis to be seven cases per 100,000 population per year, with a trend of increasing incidence 3.
  • Another study published in 2023 found that the incidence of infective endocarditis exceeds 1% per year in patients with a history of endocarditis 2.
  • The incidence of infective endocarditis increases after the age of 60, and Staphylococcus is now the most frequent responsible microorganism 2.

Trends in Incidence and Mortality

  • A study published in 2023 found that age-standardised incidence rates (ASIRs) for infective endocarditis were higher in males than females and increased in both sexes in all countries between 1990 and 2019 4.
  • The same study found that ASIRs increased for both sexes in all countries except Finland and Austria, with a recent steep rise in ASIRs noted in several countries including the UK, the USA, and Germany 4.
  • Mortality rates (ASMRs) for infective endocarditis increased for both sexes in all countries except Finland and Austria, with the largest increase in ASMR observed in females in Italy (+246%) 4.

Global Distribution

  • The incidence of infective endocarditis varies globally, with higher rates observed in industrialized countries 2.
  • A study published in 2023 found that the incidence of infective endocarditis was higher in countries such as the UK, the USA, and Germany, compared to other countries 4.

Risk Factors

  • Certain underlying heart diseases increase the risk of infective endocarditis, with an incidence exceeding 1% per year in patients with a history of endocarditis 2.
  • Age is also a risk factor, with the incidence of infective endocarditis increasing after the age of 60 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Endocarditis: epidemiology, diagnosis and treatment.

Zeitschrift fur Kardiologie, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.